Last updated on February 2018

A Study to Evaluate the Safety Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B


Brief description of study

This randomized study will be conducted in two parts to evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetics of subcutaneous administration of RO7062931. Part 1 will include only healthy participants and Part 2 will include only participants with chronic hepatitis B (CHB). Part 1 is an adaptive, single-ascending dose study with an adaptive dose-escalating schedule to determine the best dose to be evaluated in participants with CHB. Part 2 is an adaptive, parallel multiple-dose study comprised of two sub-parts which will be used to further refine the dose and dosing regimen.

Clinical Study Identifier: NCT03038113

Contact Investigators or Research Sites near you

Start Over

eference Study ID Number: BP39405 ...

Auckland Clinical Studies
Auckland, New Zealand
  Connect »

eference Study ID Number: BP39405 ...

Linear Clinical Research Limited
Nedlands, Australia
  Connect »

eference Study ID Number: BP39405 ...

Queen Mary Hospital
Hong Kong, Hong Kong
  Connect »

eference Study ID Number: BP39405 ...

The Chinese University of Hong Kong; Cheng Suen Man Shook Foundation Centre for Hepatitis Studies
Hong Kong, Hong Kong
  Connect »

eference Study ID Number: BP39405 ...

Gangnam Severance Hospital
Seoul, Korea, Republic of
  Connect »

eference Study ID Number: BP39405 ...

SMG-SNU Boramae Medical Center
Seoul, Korea, Republic of
  Connect »

eference Study ID Number: BP39405 ...

Middlemore Hospital
Auckland, New Zealand
  Connect »

eference Study ID Number: BP39405 ...

Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
  Connect »

eference Study ID Number: BP39405 ...

Chang Gung Medical Foundation - Kaohsiung Branch
Kaohsiung, Taiwan
  Connect »